Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/6/2025

Cryoprecipitate Collection and Administration

Collection and Processing Steps

  • Cryoprecipitate is manufactured by thawing fresh frozen plasma at 4 ± 2°C, which precipitates out factor VIII, factor XIII, von Willebrand factor, fibronectin, and fibrinogen, according to the Anaesthesia guideline 1
  • The process begins with obtaining fresh frozen plasma through either centrifugation of whole blood donations or apheresis collection, as recommended by the Anaesthesia guideline 1
  • The collected plasma is initially leukodepleted to reduce adverse reactions, following the Anaesthesia guideline 2
  • The plasma is then frozen and stored at temperatures below -25°C, as stated in the Anaesthesia guideline 1
  • The precipitate is then collected and resuspended in a small volume of plasma, according to the Anaesthesia guideline 3

Storage and Handling

  • Cryoprecipitate is stored at core temperatures below -25°C for up to 36 months, as recommended by the Anaesthesia guideline 1
  • Once thawed for administration, it can be kept at ambient temperature for 4 hours and should not be refrigerated again, according to the Anaesthesia guideline 2, 4
  • If there is a delay in transfusion, cryoprecipitate can be stored at ambient temperature but must be used within 4 hours, as stated in the Anaesthesia guideline 1
  • The typical infusion rate is 10-20 ml·kg⁻¹·h⁻¹, as recommended by the Anaesthesia guideline 1

Quality Control and Content

  • Each single unit of cryoprecipitate contains approximately 400-450 mg of fibrinogen, according to the Anaesthesia guideline 2, 4
  • Pools of five units contain at least 2 g of fibrinogen, as stated in the Anaesthesia guideline 2, 4
  • According to quality standards, 75% of packs should contain at least 140 mg of fibrinogen, and pooled cryoprecipitate should contain > 700 mg, as recommended by the Anaesthesia guideline 1

Special Considerations

  • For patients, cryoprecipitate is made from FFP sourced outside the UK and undergoes viral inactivation with methylene blue, according to the Anaesthesia guideline 2, 4
  • These components are available as single units for smaller individuals and pooled units for older individuals, as stated in the Anaesthesia guideline 2

Administration Guidelines

  • The adult dose is typically two pools of cryoprecipitate, as recommended by the Anaesthesia guideline 2, 4
  • Transfusion should be performed using a standard blood giving set with a 170-200 μm filter, according to the Anaesthesia guideline 1, 2, 4